Related Experiment Video
Updated: May 21, 2026
06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Flaviviruses and flavivirus vaccines
1Department of Virology, Medical University of Vienna, Kinderspitalgasse 15, 1095 Vienna, Austria. franz.x.heinz@meduniwien.ac.at
Vaccine
|June 12, 2012
Summary
Human-pathogenic flaviviruses pose global health risks. Understanding virus structure and immune responses, like antibody-dependent enhancement (ADE), is crucial for developing effective dengue vaccines.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Several flaviviruses, including dengue, yellow fever, and West Nile virus, cause significant global public health issues and can emerge in new regions.
- Structural studies of flavivirus envelope protein E and virus particles provide molecular insights into neutralization and antibody-dependent enhancement (ADE).
Purpose of the Study:
- To elucidate the molecular mechanisms of flavivirus neutralization and antibody-dependent enhancement (ADE).
- To highlight the relevance of ADE in severe dengue infections and its implications for vaccine development.
- To review the current status of flavivirus vaccine development, particularly for dengue.
Main Methods:
- X-ray crystallography to determine the atomic resolution structure of the envelope protein E.
- Cryo-electron microscopy to resolve the architecture of virus particles.
- Combination of structural and immunological investigations.
Main Results:
- Detailed molecular understanding of flavivirus neutralization mechanisms.
- Detailed molecular understanding of antibody-dependent enhancement (ADE) of infectivity.
- ADE is implicated in severe dengue pathogenesis, posing challenges for vaccine design.
Conclusions:
- Effective vaccines exist for yellow fever, Japanese encephalitis, and tick-borne encephalitis viruses.
- Dengue vaccine development is complex due to the risk of ADE and the need for broad, long-lasting immunity against all four serotypes.
- One promising dengue vaccine candidate is currently in phase 3 clinical trials.
Related Concept Videos
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...